| Literature DB >> 24121302 |
Natalia I Shtemenko1, Helen T Chifotides, Konstantin V Domasevitch, Alexander A Golichenko, Svetlana A Babiy, Zhanyong Li, Katherina V Paramonova, Alexander V Shtemenko, Kim R Dunbar.
Abstract
In this study we report the synthesis, the X-ray crystal structure and the in vivo tumor growth suppression and nephroprotective activity of bis-dimethylsulfoxide-cis-tetrachlorodi-μ-pivalatodirhenium(III), cis-Re2[(CH3)3CCOO]2Cl4·2(CH3)2SO (I). The interactions of I with DNA were also investigated by electrophoretic mobility shift assays, electronic absorption titrations, ΔTm and viscosity measurements, which indicate that compound I interacts relatively strongly with the DNA (Kb 2.2×10(3)M(-1)), most likely by forming covalent interstrand cross-links, and by kinking and unwinding supercoiled DNA; moreover, DNA cleavage by I is enhanced in the presence of redox-active species. The in vivo antitumor activity of I is considerable and is accompanied by significant elimination of red blood cell and kidney damage. Remarkably, compound I in combination with cisplatin (combined Re-Pt antitumor system) led to suppression of tumor growth or complete tumor elimination. The antihemolytic and nephroprotective abilities of I only or as a part of the Re-Pt antitumor system were established and a possible mechanism for the influence of I on these properties, involving erythropoietin production, is proposed.Entities:
Keywords: Combination therapy; DNA cleavage; Dirhenium; Tumor suppression
Mesh:
Substances:
Year: 2013 PMID: 24121302 DOI: 10.1016/j.jinorgbio.2013.09.001
Source DB: PubMed Journal: J Inorg Biochem ISSN: 0162-0134 Impact factor: 4.155